150 related articles for article (PubMed ID: 2984933)
1. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.
Firth RG; Grant CS; Riggs BL
Am J Med; 1985 Apr; 78(4):669-73. PubMed ID: 2984933
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
[TBL] [Abstract][Full Text] [Related]
3. Tertiary hyperparathyroidism after long-term phosphate supplementation in adult-onset hypophosphataemic osteomalacia.
Narváez J; Rodriguez-Moreno J; Moragues C; Campoy E; Clavaguera T; Roig-Escofet D
Br J Rheumatol; 1996 Jun; 35(6):598-600. PubMed ID: 8670586
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
Sato K; Obara T; Yamazaki K; Kanbe M; Nakajima K; Yamada A; Yanagisawa T; Kato Y; Nishikawa T; Takano K
J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
[TBL] [Abstract][Full Text] [Related]
5. [Sporadic adult hypophosphatemic vitamin D resistant osteomalacia (phosphate diabetes) and hyperparathyroidism].
Kistler HJ; Bonetti A; Frey P; Fischer JA
Schweiz Med Wochenschr; 1976 Dec; 106(51):1855-62. PubMed ID: 1013714
[TBL] [Abstract][Full Text] [Related]
6. Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia.
Su DH; Liao KM; Chang YC; Tsai KS
J Bone Miner Metab; 2006; 24(2):114-7. PubMed ID: 16502117
[TBL] [Abstract][Full Text] [Related]
7. [Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature].
Moreira RO; Leal CT; Lacativa PG; Figueiredo JG; Lima MB; Farias ML
Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):150-5. PubMed ID: 16628288
[TBL] [Abstract][Full Text] [Related]
8. Adult-onset vitamin-D-resistant hypophosphatemic osteomalacia. Effect of total parathyroidectomy.
Riggs BL; Sprague RG; Jowsey J; Maher FT
N Engl J Med; 1969 Oct; 281(14):762-6. PubMed ID: 5807923
[No Abstract] [Full Text] [Related]
9. Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis.
Weinstein RS; Harris RL
Calcif Tissue Int; 1990 Jun; 46(6):361-6. PubMed ID: 2114209
[TBL] [Abstract][Full Text] [Related]
10. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
[TBL] [Abstract][Full Text] [Related]
11. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
12. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
[TBL] [Abstract][Full Text] [Related]
13. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
14. [Tertiary hyperparathyroidism induced by the treatment of hypophosphatemic osteomalacia].
Vedere V; Goupille P; Valat JP; Lecomte P
Ann Endocrinol (Paris); 1996; 57(3):215-8. PubMed ID: 8949417
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet in the management of tumor-induced osteomalacia.
Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
[TBL] [Abstract][Full Text] [Related]
18. "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx.
Olefsky J; Kempson R; Jones H; Reaven G
N Engl J Med; 1972 Apr; 286(14):740-5. PubMed ID: 4337228
[No Abstract] [Full Text] [Related]
19. [A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].
Katagiri T; Suzuki T; Akiyama Y; Ishibashi T; Hara K; Oka H; Imai T; Kobayashi K; Kitagawa H; Ohno S
Ryumachi; 1992 Oct; 32(5):461-7; discussion 466-7. PubMed ID: 1440082
[TBL] [Abstract][Full Text] [Related]
20. Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia.
Bhadada SK; Palnitkar S; Qiu S; Parikh N; Talpos GB; Rao SD
J Clin Endocrinol Metab; 2013 Nov; 98(11):4273-8. PubMed ID: 23956343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
